M&T Bank (MTB)

NYSEFinancialsBanks - RegionalSnapshot 2026-10-15

$215.28-1.54%

Close 2026-10-16 · 1-day change

Read the published Living FV report summary

Investment OutlookAs of Oct 15, 2026

What could strengthen or challenge M&T Bank’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-0.3%

+10% or more+5%0%−5%−10% or less

21.07 → 21.01 EPS · FY ending Dec 31, 2027 · 15 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 15, 2026 to Oct 15, 2026: (new ÷ prior − 1). Contributor count changed from 14 to 15; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Living FV™

Living Fair Value by QuarterlyIQ

A valuation that evolves as the business changes.

A published Living FV snapshot is not available yet. The valuation workflow remains discoverable; a market target cannot supply the missing evidence.

View Living FV report and workflow

What the Thesis Depends On

4 key conditions need to be met for the investment thesis to play out.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Share repurchases and dividends continue at strong levels	It returns capital with $1.25 billion in share buybacks and $224 million in dividends.	Intact	capital return falls below Q1 2026 levels next year	Required source inputs unavailable Cannot calculate Cash returned to shareholders from the available matching source inputs. Missing inputs are not treated as zero. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 7 of last 7 quarters. M&T repurchased shares each quarter, including 2.1 million shares for $465 million in 2026-Q2 and announced a $5.0 billion repurchase authorization in 2026-Q1. Capital return via repurchases and dividends remains a consistent focus, with actual repurchase activity supporting the priority and capital ratios reflecting the impact. Delivery assessment Oct 15, 2026
Loan loss allowance stays near 1.53%	Credit quality stays strong with a 1.53% loan loss allowance.	Under Pressure	allowance rises above 1.6% next year	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 7 of last 7 quarters. Provision for credit losses decreased from $140 million in 2026-Q1 to $120 million in 2026-Q2; nonaccrual loans declined 3% quarter-over-quarter; allowance for loan losses as a percent of loans improved slightly to 1.52%. Management's focus on credit quality is reflected in stable or improving asset quality metrics and provision levels, indicating delivering progress. Delivery assessment Oct 15, 2026
Average loans grow to at least $138 billion	M&T Bank grows loans steadily, reaching $138 billion in Q1 2026.	Intact	average loans fall below $134 billion next year	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 7 of last 7 quarters. Average loans increased from $135.4 billion in 2025-Q2 to $141.4 billion in 2026-Q2, driven by $2.3 billion growth in commercial and industrial loans and increases in consumer and residential real estate loans. Management consistently emphasized loan portfolio growth, and the financials show delivering progress aligned with this priority. Delivery assessment Oct 15, 2026
Efficiency ratio stays near 58.3%	The bank keeps costs stable with a 58.3% efficiency ratio.	Under Pressure	efficiency ratio rises above 60% next year	Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 15, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management context Stated as a priority in 7 of last 7 quarters. Noninterest expense declined 6% from $1.415 billion in 2025-Q1 to $1.336 billion in 2025-Q2 and further to $1.349 billion in 2026-Q2. Efficiency ratio improved from 60.5% in 2025-Q1 to 52.8% in 2026-Q2. Management's focus on operational efficiency is supported by these expense reductions and improved efficiency metrics, indicating delivering progress. Delivery assessment Oct 15, 2026

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$21.01

$21.04 → $21.01 · observed estimates

FY2027 revenue$10.43B

$10.40B → $10.43B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$21.04	$10,401,490,268	13 / 7
2026-07-25	$21.04	$10,401,490,268	13 / 7
2026-07-26	$21.04	$10,383,973,940	15 / 10
2026-07-27	$21.04	$10,408,609,221	13 / 8
2026-07-28	$21.04	$10,408,609,221	13 / 8
2026-07-29	$21.04	$10,383,973,940	15 / 10
2026-07-30	$21.04	$10,408,609,221	13 / 8
2026-07-31	$21.05	$10,391,174,240	15 / 10
2026-08-01	$21.04	$10,413,398,178	13 / 8
2026-08-02	$21.05	$10,391,174,240	15 / 10
2026-08-03	$21.04	$10,413,398,178	13 / 8
2026-08-04	$21.05	$10,391,174,240	15 / 10
2026-08-05	$21.04	$10,413,398,178	13 / 8
2026-08-06	$21.07	$10,399,711,320	15 / 10
2026-08-07	$21.07	$10,419,065,783	13 / 8
2026-08-08	$21.07	$10,419,065,783	13 / 8
2026-08-09	$21.07	$10,399,711,320	15 / 10
2026-08-10	$21.07	$10,399,711,320	15 / 10
2026-08-12	$21.07	$10,419,065,783	13 / 8
2026-08-13	$21.07	$10,419,065,783	13 / 8
2026-08-14	$21.07	$10,419,065,783	13 / 8
2026-08-15	$21.07	$10,419,065,783	13 / 8
2026-08-16	$21.07	$10,419,065,783	13 / 8
2026-08-17	$21.07	$10,419,065,783	13 / 8
2026-08-18	$21.07	$10,419,065,783	13 / 8
2026-08-19	$21.07	$10,419,065,783	13 / 8
2026-08-20	$21.07	$10,419,065,783	13 / 8
2026-08-21	$21.07	$10,419,065,783	13 / 8
2026-08-22	$21.07	$10,419,065,783	13 / 8
2026-08-23	$21.07	$10,419,065,783	13 / 8
2026-08-24	$21.07	$10,419,065,783	13 / 8
2026-08-25	$21.07	$10,419,065,783	13 / 8
2026-08-26	$21.07	$10,419,065,783	13 / 8
2026-08-27	$21.07	$10,419,065,783	13 / 8
2026-08-28	$21.07	$10,419,065,783	13 / 8
2026-08-29	$21.07	$10,419,065,783	13 / 8
2026-08-30	$21.07	$10,419,065,783	13 / 8
2026-08-31	$21.07	$10,419,065,783	13 / 8
2026-09-01	$21.07	$10,419,065,783	13 / 8
2026-09-02	$21.07	$10,419,065,783	13 / 8
2026-09-03	$21.07	$10,419,065,783	13 / 8
2026-09-04	$21.07	$10,419,065,783	13 / 8
2026-09-05	$21.07	$10,422,570,482	13 / 8
2026-09-06	$21.07	$10,422,570,482	13 / 8
2026-09-07	$21.07	$10,422,570,482	13 / 8
2026-09-08	$21.07	$10,425,570,482	13 / 8
2026-09-09	$21.07	$10,434,142,807	13 / 8
2026-09-10	$21.07	$10,435,428,521	13 / 8
2026-09-11	$21.07	$10,435,428,521	13 / 8
2026-09-12	$21.07	$10,435,428,521	14 / 8
2026-09-13	$21.07	$10,435,428,521	14 / 8
2026-09-14	$21.07	$10,435,428,521	14 / 8
2026-09-15	$21.07	$10,435,428,521	14 / 8
2026-09-16	$21.07	$10,435,999,950	14 / 8
2026-09-17	$21.07	$10,435,999,950	14 / 8
2026-09-18	$21.07	$10,435,999,950	14 / 8
2026-09-19	$21.07	$10,435,999,950	14 / 8
2026-09-20	$21.07	$10,435,999,950	14 / 8
2026-09-21	$21.07	$10,435,999,950	14 / 8
2026-09-22	$21.07	$10,435,999,950	14 / 8
2026-09-23	$21.07	$10,436,793,357	14 / 8
2026-09-24	$21.07	$10,436,793,357	14 / 8
2026-09-25	$21.06	$10,434,064,496	14 / 8
2026-09-26	$21.06	$10,434,064,496	14 / 8
2026-09-27	$21.06	$10,434,064,496	14 / 8
2026-09-28	$21.06	$10,435,154,293	14 / 8
2026-09-29	$21.06	$10,435,154,293	14 / 8
2026-09-30	$21.06	$10,435,154,293	14 / 8
2026-10-01	$21.06	$10,445,439,269	14 / 8
2026-10-02	$21.05	$10,444,076,087	14 / 8
2026-10-03	$21.04	$10,442,461,637	14 / 8
2026-10-04	$21.04	$10,442,461,637	14 / 8
2026-10-05	$21.04	$10,442,461,637	14 / 8
2026-10-06	$21.02	$10,435,571,191	14 / 8
2026-10-07	$21.00	$10,433,878,883	14 / 8
2026-10-08	$20.99	$10,424,833,330	15 / 9
2026-10-09	$21.01	$10,425,019,604	15 / 10
2026-10-10	$21.01	$10,425,019,604	15 / 10
2026-10-11	$21.01	$10,425,019,604	15 / 10
2026-10-12	$21.01	$10,425,019,604	15 / 8
2026-10-13	$21.01	$10,425,019,604	15 / 8
2026-10-14	$21.01	$10,425,019,604	15 / 8
2026-10-15	$21.01	$10,425,019,604	15 / 8

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold	Sell*
2026-05-01	7	13	1
2026-06-01	6	13	1
2026-07-01	6	15	1
2026-08-01	4	15	1
2026-09-01	5	15	1
2026-10-01	6	15	1

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 6 Buy / Strong Buy · 15 Hold · 1 Sell / Strong Sell

0 upgrades0 downgrades6 maintains

Recent actions · Sep 16–Oct 15 · 6 recorded

Price-target changes

30 days

○ Previous · ● Latest · common dollar scale

Cantor FitzgeraldOct 14 · prior Aug 19

$285.00 → $255.00-10.5%

Raymond JamesOct 6

$250.00New observation · no comparable prior

UBSOct 5 · prior Aug 3

$255.00 → $238.00-6.7%

Evercore ISIOct 1 · prior Jul 6

$260.00 → $230.00-11.5%

Morgan StanleySep 28 · prior Sep 8

$304.00 → $301.00-1.0%

Truist FinancialSep 23 · prior Jul 21

$268.00 → $250.00-6.7%

$0$167.20$334.40

0 raises · 5 cuts · 0 unchanged · 1 without a comparable prior

How this is measured

Sep 16, 2026–Oct 15, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Share repurchases and dividends continue at strong levelsRequired source inputs unavailable
Loan loss allowance stays near 1.53%Published status: Under Pressure
Average loans grow to at least $138 billionDirect metric needs a verified mapping
Efficiency ratio stays near 58.3%Published status: Under Pressure

Next proof point

Oct 16, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

0.8%Typical daily move · historical

Downside history

-17.0%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

M&T Bank outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 10, 2026

What kind of bet this is

This investment is characterized as a durable compounder with a stable management team. The current thesis state is intact, as recent financial performance remains strong compared to industry peers.

What's priced into M&T Bank

The market appears to have priced in a neutral valuation, with M&T Bank being viewed as cheap compared to its peers. There is a slight expectations gap, indicating that the market may not fully anticipate potential upside from management's priorities.

What the fundamentals likely do

Fundamentals are likely to show mixed results in the near term. While loan portfolio growth is on track, management's focus on maintaining strong credit quality is behind schedule, which could impact future performance.

What M&T Bank hinges on

The thesis hinges on the performance of sector bellwethers like HDB, IBN, and USB. If these companies continue to perform well, it could provide a favorable backdrop for M&T Bank. Conversely, any negative guidance from these peers could weigh on M&T's prospects.